Viewing Study NCT00741260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-01-03 @ 8:36 PM
Study NCT ID: NCT00741260
Status: COMPLETED
Last Update Posted: 2018-09-05
First Post: 2008-08-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
Sponsor: Puma Biotechnology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumor View
None erbB2+ Breast Cancer View
None Prior trastuzumab View
None Metastatic View
None Neratinib View
None HKI-272 View
None Nerlynx View
None HER2 View
None PB-272 View